REFIXIA subst sèche 3000 UI c solv flac

7680662160040 CH-66216 B02BD04 06.01.1.

Reimbursement limitations:

BLUTPRODUKTE

Calcul des prix des préparations sanguines sur la base du prix « ex factory », …

REFIXIA subst sèche 3000 UI c solv flac
REFIXIA subst sèche 3000 UI c solv flac
REFIXIA subst sèche 3000 UI c solv flac
1 / 3
google

Details

Product number
6621604
CPT
-
Packaging group
-
Unit
(1 Durchstechflasche mit Pulver und 1 Fertigspritze mit Lösungsmittel) und Verabreichungsset
Composition
Praeparatio cryodesiccata: nonacogum beta pegolum 3000 U.I., natrii chloridum, histidinum, saccharum 10 mg, mannitolum, polysorbatum 80, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, pro vitro corresp. natrium 0.972 mg/ml. Solvens: histidinum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium.

Articles (1)

Refixia 3000 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
29/01/2025
Patient information leaflet
Français
29/01/2025
Patient information leaflet
Italien
29/01/2025
Professional SmPC
Allemand
29/01/2025
Professional SmPC
Français
29/01/2025
Professional SmPC
Italien
29/01/2025

Detailed composition

Substance Quantity Type Category
SOLV
- Substance HNIDK
PRC
3000.0 UI Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
SOLV
- Substance HNIDK
PRC
- Substance HNIDK
SOLV
- Substance HNIDK
SOLV
- Substance HNIDK
PRC
10.0 MG Substance HBESI
PRC
- Substance HNIDK
PRC
- Substance HNIDK
SOLV
- Substance HBESI
PRC
- Substance HNIDK
PRC
- Substance HNIDK
PRC
0.972 MGML Substance HBESI

Reimbursement information

Public price
CHF 5516.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2024

Authorization holder

Novo Nordisk Pharma AG

8302 Kloten

Authorization information

Swissmedic authorization number
66216
Drug name
Refixia, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
PULMJ
ATC Code
B02BD04
Authorization status
Z
Dispensation category
B
First authorization
05/09/2017
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
Hämophilie B

Packaging details

Description (FR)
REFIXIA subst sèche 3000 UI c solv flac
Description (DE)
REFIXIA Trockensub 3000 IE c Solv Durchstf
Market launch
19/12/2023
Narcotic (BTM)
No

Other packaging sizes

REFIXIA subst sèche 500 UI c solv flac
None LEER
View
REFIXIA subst sèche 1000 UI c solv flac
None LEER
View
REFIXIA subst sèche 2000 UI c solv flac
None LEER
View